How Membrane Solutions Sterile Syringe Filters Enabled Key Discovery in Colorectal Cancer Immunotherap

2026-02-09

MS

20

In the field of cancer therapy, activating patients'own immune system to attack tumors has always been a core focus of both research and clinical practice. Especially for the majority of microsatellite-stable (MSS) colorectal cancer patients, traditional immune checkpoint inhibitors show limited efficacy, making it urgent to identify new therapeutic targets and intervention strategies.

 

Recently, a research team from Tongji Hospital, Huazhong University of Science and Technology published an important study titled Palmitic acid-triggered B7H3 palmitoylation promotes immune escape in Nature Communications. This study deeply elucidates a novel immune evasion mechanism in colorectal cancer. During a critical experimental step—filtering lentiviral supernatant to construct stable cell lines—the researchers utilized Membrane Solutions sterile syringe filters. This reliable consumable provided essential support for the integrity and success of the study.

 

Published Journal: Nature Communications

DOI: 10.1038/s41467-026-68525-x

 

 

Key Scientific Findings: Revealing the Key Mechanism of Colorectal Cancer Immune Evasion

This study focuses on the palmitic acid-triggered B7H3 palmitoylation regulatory pathway, elucidating, for the first time, a novel molecular mechanism of immune evasion in colorectal cancer, providing a breakthrough therapeutic target for MSS colorectal cancer immunotherapy.

 Targeting the Core Molecule B7H3

The study confirmed that the immune checkpoint protein B7H3 is specifically highly expressed in MSS colorectal cancer, its protein stability is regulated by palmitoylation modification, and its expression is significantly associated with poor patient prognosis.

 Elucidating a Novel Regulatory Mechanism

Accumulated palmitic acid in the tumor microenvironment can catalyze B7H3 palmitoylation via the palmitoyltransferase ZDHHC24, preventing its recognition and degradation by the autophagy receptor SQSTM1/p62. This leads to protein stabilization and suppression of CD8⁺ T cell antitumor activity.

 Proposing Potential Therapeutic Strategies

The team successfully designed a cell-penetrant peptide (E-peptide) that specifically blocks the ZDHHC24-B7H3 interaction, effectively reducing B7H3 stability and activating T cell immune responses. Combined with PD-1 inhibitors, it shows significant synergistic antitumor effects.

 

 

Supporting Product: Membrane Solutions Sterile Syringe Filter

Model: SFPES025022SI

 

 

Engineered for Critical Research: Four Core Advantages

As a “trusted choice” in cutting-edge research, the core competitiveness of Membrane Solutions sterile filters comes from deep adaptation to research applications:

 Strict Sterility Assurance:

The product is sterilized by irradiation, with a sterility assurance level (SAL) of 10⁻⁶. Each filter is individually packaged to effectively prevent contamination and is ready to use.

 Excellent Membrane Performance:

Using low-protein-binding polyethersulfone (PES) membranes, it ensures high recovery of viruses, proteins, cytokines, and other bioactive molecules. Through ASTM bacterial challenge tests, 0.22 μm filters achieve a log reduction value (LRV) > 7 for bacterial retention.

 Broad Solution Compatibility:

Endotoxin-free, surfactant-free, and low extractables make it suitable for gentle, rapid filtration of culture media, protein solutions, buffers, and other biological fluids.

 Flexible Specifications:

Available in multiple effective filtration areas (EFA) to accommodate different sample volumes and can be paired with a glass fiber pre-filter layer to easily process samples containing minor particulates or slightly viscous solutions.

 

Membrane Solutions: Empowering Research with Reliable Quality

This application in a pivotal colorectal cancer study highlights the critical role Membrane Solutions sterile syringe filters can play at the forefront of tumor immunology. It validates the product's reliability and performance in highly sensitive, high-standard biological experiments.

From mechanistic studies to therapeutic development, breakthroughs in top-tier biomedical research rely on the utmost reliability at every experimental step. Membrane Solutions is committed to providing high-quality consumables that form a reliable foundation for research. We support scientists in pushing the boundaries of life sciences, enabling innovation through our expertise, and contributing to trustworthy, reproducible discoveries.

We are convinced that reliable experimental tools are indispensable for scientific progress. Membrane Solutions will continue to focus on filtration technology and quality upgrades, providing stable, efficient, and dependable support for life science explorers, and jointly promoting the translation of more human health-benefiting outcomes.